00000nam 2200000zi 4500 9.893236 CaOODSP 20240517093244 m o d f cr cn||||||||| 201104t20212021oncad obs f000 0 eng d 9780660365596 CaOODSP eng rda CaOODSP n-cn--- HP40-206/2020E-PDF Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) : results from 2015 to 2017. Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) – results from 2015-2017 Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2021. ©2021 1 online resource (iv, 46 pages) : illustrations, graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier "February 2021." Cover title. Issued also in HTML format. Issued also in French under title: Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) : résultats de 2015 à 2017. Includes bibliographical references (pages 35-38). "In Canada and globally, rates of sexually transmitted infections (STI) continue to rise and remain a serious public health threat. Gonorrhea is the most commonly reported drug resistant STI and the second most common bacterial STI in Canada with over 29,000 cases reported in 2017. Worldwide, an estimated 87 million new cases of gonorrhea were reported in 2016"--Introduction, page 4. Gonorrhea Canada Statistics. Gonorrhea Treatment Canada. Public Health Agency of Canada, issuing body. Rapport sur le système de surveillance accrue de la résistance de la gonorrhée aux antimicrobiens (SARGA) : (CaOODSP)9.893238 Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) : (CaOODSP)9.938400 Report on the enhanced surveillance of antimicrobial-resistant gonorrhea (ESAG) : 2014-2015 (CaOODSP)9.870670 PDF 2.09 MB https://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-206-2020-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/diseases-conditions/2015-2017-report-enhanced-surveillance-antimicrobial-resistant-gonorrhea.html 200273